Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
| Operating Expenses | 0 | 2,723 | 2,552 | 0 |
| Operating Income | N/A | -2,723 | -2,552 | N/A |
| Other Income | 0 | 86 | 3 | 0 |
| Pre-tax Income | 0 | -2,637 | -2,549 | 0 |
| Net Income Continuous | N/A | -2,637 | -2,549 | N/A |
| Net Income | $N/A | $-2,637 | $-2,549 | $N/A |
| EPS Basic Total Ops | N/A | -9.64 | -10.21 | N/A |
| EPS Basic Continuous Ops | N/A | -8.04 | -8.47 | N/A |
| EPS Diluted Total Ops | N/A | -9.64 | -10.21 | N/A |
| EPS Diluted Continuous Ops | N/A | -8.04 | -8.47 | N/A |
| EBITDA(a) | $N/A | $-2,721 | $-2,552 | $N/A |